Considering that we have previously demonstrated that the MRP4 structural and functional changes led to a reduced efflux of cGMP and then accumulation within RBCs from hemodialysis subjects [8], here we hypothesized that this mechanism might be differently affected by the therapies employed for the treatment of CKD. This evidence concerns the gene ABCC4 and chronic kidney disease.